Investing.com -- Wall Street banks have launched coverage of NIQ Global Intelligence (NYSE: NIQ ), with analysts highlighting ...

Wegovy becomes the first GLP-1 based therapy authorized for MASH, which affects roughly 5% of U.S. adults, according to the ...

Investing.com -- U.S. software stocks may see short-term gains in the current earnings cycle, even as questions over ...

Investing.com - U.S. stock futures were muted ahead of a high-stakes meeting between President Donald Trump and Ukrainian President Volodymyr Zelensky in Washington. The outlook for the Federal ...